Reuters logo
BRIEF-Altimmune submits investigational new drug application for Nasovax for phase 2 trial preparation
August 21, 2017 / 12:06 PM / 3 months ago

BRIEF-Altimmune submits investigational new drug application for Nasovax for phase 2 trial preparation

Aug 21 (Reuters) - Altimmune Inc

* Altimmune submits investigational new drug application for Nasovax in preparation for Phase 2 trial

* Previous versions of Nasovax evaluated in two phase 1 studies under earlier inds were immunogenic and well tolerated

* Phase 2 data is expected sometime in Q1 of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below